Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407809 · ClinicalTrials.gov registry record · Phase 1
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
A Phase 1 study of Idiopathic Intracranial Hypertension (IIH), sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01407809: Completed Phase 1 study of Idiopathic Intracranial Hypertension (IIH), sponsored by Weill Medical College of Cornell University.
NCT01407809 is a Phase 1 study of Idiopathic Intracranial Hypertension (IIH) that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01407809, a Phase 1 study of Idiopathic Intracranial Hypertension (IIH), has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Idiopathic Intracranial Hypertension (IIH) is a disease that affects mainly young people, and is associated with headache and loss of vision. The medical and surgical management of IIH is problematic and many patients are not treated effectively. Some cases of IIH are associated with severe stenosis of the large veins of the brain and various researchers have recently reported significant improvement in patients with IIH after the narrow veins of the brain were treated with a stent. Our project aims to evaluate the safety and long-term efficacy of venous sinus stenting in patients with severe IIH refractory to medical management.
Conditions Studied
Interventions
- DEVICE Venous Sinus Stenting
Study Locations (1)
New York
- New York Presbyterian/ Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2020-06-01 |
| Phase | Phase 1 |
What the finished NCT01407809 record still lists
NCT01407809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Idiopathic Intracranial Hypertension (IIH) appearing as the primary indexed condition, and to 1 intervention - of which Venous Sinus Stenting is the first listed.
NCT01407809 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01407809 about?
NCT01407809 is a clinical study titled "Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy". Idiopathic Intracranial Hypertension (IIH) is a disease that affects mainly young people, and is associated with headache and loss of vision. The medical and surgical management of IIH is problematic and many patients are not treated effectively. Some cases of IIH are associated with severe stenosis...
What is the current status of trial NCT01407809?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2020-06-01.
What conditions does trial NCT01407809 study?
This clinical trial studies the following conditions: Idiopathic Intracranial Hypertension (IIH).
What interventions are being tested in trial NCT01407809?
The interventions under investigation include: Venous Sinus Stenting (DEVICE).
Who is sponsoring clinical trial NCT01407809?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01407809 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Idiopathic Intracranial Hypertension (IIH)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01407809's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia